Frontline Brentuximab Vedotin And Chp (A+Chp) In Patients With Peripheral T-Cell Lymphoma With Less Than 10% Cd30 Expression: Initial Safety And Efficacy Results From The Phase 2 Study Sgn35-032
Brentuximab Vedotin;CHP
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Frontline Brentuximab Vedotin And Chp (A+Chp) In Patients With Peripheral T-Cell Lymphoma With Less Than 10% Cd30 Expression: Initial Safety And Efficacy Results From The Phase 2 Study Sgn35-032 ### Output: Brentuximab Vedotin;CHP